37 results on '"Munro, Alison F."'
Search Results
2. The autophagy protein Ambra1 regulates gene expression by supporting novel transcriptional complexes
3. High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery
4. High content phenotypic screening identifies serotonin receptor modulators with selective activity upon breast cancer cell cycle and cytokine signaling pathways
5. A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials
6. A targetable PREX2/RAC1/PI3Kβ signalling axis confers resistance to clinically relevant therapeutic approaches in melanoma
7. A cautionary note on the use of N-acetylcysteine as a reactive oxygen species antagonist to assess copper mediated cell death
8. A cautionary note on the use of N-acetylcysteine as a reactive oxygen species antagonist to assess copper mediated cell death.
9. Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts
10. Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches
11. Supplementary Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
12. Data from A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
13. Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells
14. Distinct neuroinflammatory signatures exist across genetic and sporadic ALS cohorts
15. Multiparametric High-Content Cell Painting Identifies Copper Ionophores as Selective Modulators of Esophageal Cancer Phenotypes
16. Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
17. A novel mode of inhibiting SRC improves drug efficacy and tolerability
18. High-content profiling reveals a unified model of copper ionophore dependent cell death in oesophageal adenocarcinoma
19. GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients
20. In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
21. The p160 ER co-regulators predict outcome in ER negative breast cancer
22. A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
23. A conformation selective mode of inhibiting SRC improves drug efficacy and tolerability
24. Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial
25. Supplemental_Material_for__high_content_phenotypic_profiling_by_Hughes,_et_al – Supplemental material for High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery
26. High Content Phenotypic Profiling in Oesophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery
27. Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action
28. Rapid Discovery and Structure–Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase
29. Predicting Anthracycline Benefit: TOP2A and CEP17—Not Only but Also
30. Abstract P2-05-05: A four gene signature predicts anthracycline benefit: Evidence from the BR9601 and MA5 breast cancer trials
31. Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
32. Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
33. In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
34. The p160 ER co-regulators predict outcome in ER negative breast cancer
35. The Role of HER1-HER4 and EGFRvIII in Hormone-Refractory Prostate Cancer
36. Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer
37. Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.